Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,660 | 2,600 | 2,516 | 2,872 | 5,633 |
| Income taxes - deferred | N/A | N/A | N/A | -6 | 113 |
| Accounts receivable | -63 | -1,563 | 6,420 | 3,618 | 16,983 |
| Other Working Capital | -25 | 1,652 | 3,450 | 6,245 | 21,828 |
| Other Operating Activity | -7,076 | -7,550 | -24,725 | -28,798 | -57,770 |
| Operating Cash Flow | $-5,504 | $-4,861 | $-12,339 | $-16,069 | $-13,213 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65 | 347 | 178 | 7 | 311 |
| Net Acquisitions | N/A | 0 | 5,262 | 6,014 | N/A |
| Other Investing Activity | 4,685 | 66 | 1,432 | -863 | -276 |
| Investing Cash Flow | $4,620 | $413 | $6,872 | $5,158 | $35 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -608 | -2,915 | -696 | N/A | N/A |
| Debt Issued | 500 | 799 | N/A | 1,341 | 0 |
| Debt Repayment | -84 | -136 | -248 | -948 | -2,962 |
| Common Stock Issued | N/A | N/A | N/A | 0 | 30,917 |
| Other Financing Activity | 174 | 405 | 576 | 403 | -151 |
| Financing Cash Flow | $-18 | $-1,847 | $-368 | $796 | $27,804 |
| Exchange Rate Effect | 18 | 4 | -329 | 150 | -429 |
| Beginning Cash Position | 11,690 | 17,981 | 24,145 | 34,110 | 19,913 |
| End Cash Position | 10,806 | 11,690 | 17,981 | 24,145 | 34,110 |
| Net Cash Flow | $-902 | $-6,295 | $-5,835 | $-10,115 | $14,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,504 | -4,861 | -12,339 | -16,069 | -13,213 |
| Capital Expenditure | -100 | -154 | -471 | -863 | -783 |
| Free Cash Flow | -5,604 | -5,015 | -12,810 | -16,932 | -13,996 |